Skip to main content
. Author manuscript; available in PMC: 2021 Jul 19.
Published in final edited form as: Free Radic Biol Med. 2020 May 6;154:105–118. doi: 10.1016/j.freeradbiomed.2020.04.029

Table 1. Yeast gene candidates selected for screening.

Group 1 Genes with diminished response to exogenous CoQ2 and CoQ4 [39] ZDS1, RTS1, IKI3, ELP4, QCR9, ACO1, MDL2, SAC1, SWF1, ARV1, CDC10, KCS1, EMI1, MET18, RPL31A, HTA1, CSR1, HES1
Group 2 Yeast major clathrin-mediated endocytic factors [53] SYP1, EDE1, CHC1, CLC1, SLA2, END3, SLA1, VRP1, BZZ1, MYO3, MYO5, BBC1, RVS161, RVS167, ABP1
Group 3 ER-mitochondria encounter structure (ERMES) MMM1, MDM10, MDM12, MDM34
Group 4 Nucleous-vacuole junction (NVJ) VAC8, NVJ1
Group 5 Vacuole-mitochondria patch (vCLAMP) YPT7, VAM6, VAM7
Group 6 Genes previously described to be required for CoQ6 rescue [33] TLG2, PEP12, ERG2, VPS45
Group 7 Nat B complex MDM20, NAT3

Genes depicted in light grey represent the ORFΔcoq2Δ double mutants that were not recoverable for the ORFΔcoq2Δ library.